Vertical transmission of HIV: where to now?

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.279, 2000-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharma-sponsored DM: where to now?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 297, 2001-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Pharmacotherapies for Obstructive Sleep Apnoea: Where Are We Now?

By Smith I.E. Quinnell T.G.

Drugs, Vol. 64, Iss. 13, 2004-01 ,pp. : 1385-1399

Adis International

Access to resources Recommend Favorite

High-Dose Chemotherapy and Stem Cell Support for Breast Cancer: Where Are We Now?

By Gerrero R.M. Stein S. Stadtmauer E.A.

Drugs & Aging, Vol. 19, Iss. 7, 2002-01 ,pp. : 475-485

Adis International

Access to resources Recommend Favorite

Zidovudine + lamivudine to prevent vertical HIV transmission?

Inpharma, Vol. 1, Iss. 1286, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Could epoetin-alfa prevent vertical HIV transmission?

Inpharma, Vol. 1, Iss. 1361, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite